Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$6.06 - $12.86 $253,083 - $537,072
41,763 Added 120.29%
76,482 $463,000
Q2 2022

Aug 11, 2022

BUY
$8.35 - $21.89 $289,903 - $759,998
34,719 New
34,719 $363,000
Q4 2021

Mar 11, 2022

SELL
$25.61 - $41.78 $441,234 - $719,827
-17,229 Closed
0 $0
Q2 2021

Aug 19, 2021

SELL
$17.48 - $25.46 $301,267 - $438,803
-17,235 Reduced 50.01%
17,229 $390,000
Q1 2021

Apr 26, 2021

SELL
$18.08 - $28.8 $581,344 - $926,035
-32,154 Reduced 48.27%
34,464 $789,000
Q4 2020

Feb 11, 2021

BUY
$11.7 - $23.41 $779,430 - $1.56 Million
66,618 New
66,618 $1.45 Million
Q2 2019

Aug 08, 2019

SELL
$17.0 - $21.88 $2.66 Million - $3.42 Million
-156,505 Closed
0 $0
Q1 2019

May 02, 2019

SELL
$15.53 - $22.15 $47,832 - $68,222
-3,080 Reduced 1.93%
156,505 $3.21 Million
Q4 2018

Jan 30, 2019

SELL
$14.06 - $22.57 $3.77 Million - $6.05 Million
-267,880 Reduced 62.67%
159,585 $2.67 Million
Q3 2018

Oct 31, 2018

SELL
$13.35 - $19.1 $230,060 - $329,150
-17,233 Reduced 3.88%
427,465 $7.33 Million
Q2 2018

Jul 31, 2018

SELL
$10.35 - $16.45 $59,791 - $95,031
-5,777 Reduced 1.28%
444,698 $6.4 Million
Q1 2018

May 07, 2018

BUY
$8.0 - $12.8 $3.6 Million - $5.77 Million
450,475 New
450,475 $4.96 Million

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $335M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Bradley Foster & Sargent Inc Portfolio

Follow Bradley Foster & Sargent Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bradley Foster & Sargent Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bradley Foster & Sargent Inc with notifications on news.